Applied BioCode Asset Resilience Ratio

Latest as of September 2025: 9.75%

Applied BioCode asset resilience ratio. Applied BioCode (6598) has an Asset Resilience Ratio of 9.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Applied BioCode defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$100.55 Million

≈ $3.17 Million USD Cash + Short-term Investments

Total Assets

NT$1.03 Billion

≈ $32.48 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Applied BioCode (2012–2024)

Asset resilience ratio of Applied BioCode from 2012 to 2024. This chart shows how Applied BioCode's Asset Resilience Ratio has changed over time. Read 6598 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Applied BioCode's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 6598 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$100.55 Million	9.75%
Total Liquid Assets	NT$100.55 Million	9.75%

Asset Resilience Insights

Limited Liquidity: Applied BioCode maintains only 9.75% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Applied BioCode Industry Peers by Asset Resilience Ratio

Compare Applied BioCode's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Tellgen Corp SHE:300642	Medical Devices	12.10%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	3.90%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Pulsenmore Ltd TA:PULS	Medical Devices	51.61%
Adherium Ltd AU:ADR	Medical Devices	15.45%

Applied BioCode Asset Resilience Ratio by Year (2012–2024)

Applied BioCode asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Applied BioCode.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.70%	NT$251.53 Million ≈ $7.92 Million	NT$1.21 Billion ≈ $38.28 Million	+1.41pp
2023-12-31	19.29%	NT$191.62 Million ≈ $6.04 Million	NT$993.21 Million ≈ $31.29 Million	+2.42pp
2019-12-31	16.87%	NT$121.33 Million ≈ $3.82 Million	NT$719.01 Million ≈ $22.65 Million	+16.57pp
2018-12-31	0.30%	NT$1.54 Million ≈ $48.61K	NT$514.07 Million ≈ $16.20 Million	+0.04pp
2017-12-31	0.26%	NT$890.00K ≈ $28.04K	NT$336.83 Million ≈ $10.61 Million	-69.42pp
2016-12-31	69.69%	NT$333.63 Million ≈ $10.51 Million	NT$478.77 Million ≈ $15.08 Million	+50.99pp
2015-12-31	18.69%	NT$58.14 Million ≈ $1.83 Million	NT$310.99 Million ≈ $9.80 Million	+2.99pp
2014-12-31	15.71%	NT$55.70 Million ≈ $1.75 Million	NT$354.66 Million ≈ $11.17 Million	+4.16pp
2013-12-31	11.55%	NT$22.47 Million ≈ $707.93K	NT$194.56 Million ≈ $6.13 Million	+3.27pp
2012-12-31	8.28%	NT$21.79 Million ≈ $686.35K	NT$262.99 Million ≈ $8.29 Million	--

pp = percentage points

About Applied BioCode

TW:6598 Taiwan Medical Devices

Market Cap

$91.98 Million

NT$2.92 Billion TWD

Market Cap Rank

#19332 Global

#1111 in Taiwan

Share Price

NT$28.40

Change (1 day)

-2.41%

52-Week Range

NT$20.55 - NT$31.50

All Time High

NT$177.50